Page last updated: 2024-09-03

glabridin and Lung Injury, Acute

glabridin has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, YH; Liu, GJ; Yang, DG; Zhang, LP; Zhao, Y; Zhou, LH	1

Other Studies

1 other study(ies) available for glabridin and Lung Injury, Acute

Article	Year
Glabridin attenuates lipopolysaccharide-induced acute lung injury by inhibiting p38MAPK/ERK signaling pathway. Oncotarget, 2017, Mar-21, Volume: 8, Issue:12 Topics: Acute Lung Injury; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Isoflavones; Lipopolysaccharides; Male; MAP Kinase Signaling System; Phenols; Random Allocation; Rats; Rats, Wistar; Respiratory Distress Syndrome	2017

Article

Year

Glabridin attenuates lipopolysaccharide-induced acute lung injury by inhibiting p38MAPK/ERK signaling pathway.

Oncotarget, 2017, Mar-21, Volume: 8, Issue:12

Topics: Acute Lung Injury; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Isoflavones; Lipopolysaccharides; Male; MAP Kinase Signaling System; Phenols; Random Allocation; Rats; Rats, Wistar; Respiratory Distress Syndrome

2017